The CRC-liver signature was characterized by proliferation/transcription and metabolic pathways while the CRC-peritoneum signature was associated with metastatic dissemination including the EMT, stem cell pathways and the inflammatory signaling mediated by IL6 and STAT-3. This evidence concerns the gene STAT3 and colorectal carcinoma.